CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-19 | Poliakoff Abba David Director | Option exercise | +10,000 | $5.43 | $54K | 90,147 |
| 2021-01-19 | Poliakoff Abba David Director | Shares withheld for taxes | +8,873 | $11.53 | $102K | 81,274 |
| 2021-01-19 | Poliakoff Abba David Director | Option exercise · Option to purchase Common Stock | −10,000 | 0 | ||
| 2021-01-19 | Poliakoff Abba David Director | Option exercise · Option to purchase Common Stock | −10,000 | 0 | ||
| 2021-01-19 | Poliakoff Abba David Director | Option exercise · Option to purchase Common Stock | −10,000 | 0 | ||
| 2020-12-16 | Breitfeld Philip P. Director | Sale | −31,443 | $11.35 | $357K | 0 |
| 2020-12-08 | Mendelson Daniel Newman Director | Grant or award · Option to purchase Common Stock | +10,000 | $11.96 | $120K | 10,000 |
| 2020-12-08 | SIDRANSKY DAVID Director | Grant or award · Option to purchase Common Stock | +8,333 | $11.96 | $100K | 8,333 |
| 2020-12-08 | ACKERMAN JOEL Director | Grant or award · Option to purchase Common Stock | +16,667 | $11.96 | $199K | 16,667 |
| 2020-12-08 | Poliakoff Abba David Director | Grant or award · Option to purchase Common Stock | +2,500 | $11.96 | $30K | 2,500 |
| 2020-12-08 | Breitfeld Philip P. Director | Grant or award · Option to purchase Common Stock | +8,333 | $11.96 | $100K | 8,333 |
| 2020-12-08 | TOBIN SCOTT R Director | Grant or award · Option to purchase Common Stock | +10,000 | $11.96 | $120K | 10,000 |
| 2020-10-30 | TOBIN SCOTT R Director | Option exercise | +10,000 | $5.46 | $55K | 10,000 |
| 2020-10-30 | TOBIN SCOTT R Director | Option exercise · Stock Options | −10,000 | 0 | ||
| 2020-10-16 | SIDRANSKY DAVID Director | Option exercise | +16,667 | $5.46 | $91K | 758,334 |
| 2020-10-16 | SIDRANSKY DAVID Director | Shares withheld for taxes | −10,100 | $9.01 | $91K | 748,234 |
| 2020-10-16 | SIDRANSKY DAVID Director | Option exercise · Option to purchase Common Stock | −16,667 | 0 | ||
| 2020-03-26 | Mendelson Daniel Newman Director | Purchase | +20 | $6.00 | $120 | 57,546 |
| 2020-03-26 | Mendelson Daniel Newman Director | Purchase | +100 | $5.99 | $599 | 57,646 |
| 2020-03-26 | Mendelson Daniel Newman Director | Purchase | +100 | $5.97 | $597 | 57,746 |
Page 6 of 20 · 398 trades